Status of adjuvant endocrine therapy for breast cancer

Gaia Schiavon and Ian E Smith

Breast Cancer Research 2014, 16:206 (1 April 2014)

Smith and Schiavon review adjuvant endocrine therapy for hormone receptor-positive early breast cancer, discussing how extended therapy for selected patients with tamoxifen or an aromatase inhibitor (AI) further reduces risk of relapse.

Subscription required

All research articles in Breast Cancer Research are open access. The journal also publishes a range of other articles that are available to subscribers.

Existing subscribers

Forgotten your password? help